HTR3C: A Promising Drug Target / Biomarker (G170572)

Target Name: HTR3C

NCBI ID: G170572

HTR3C

HTR3C: A Promising Drug Target / Biomarker

Human tissue factor (Htf) is a protein that is expressed in various tissues of the human body, including the heart, kidneys, liver, and stem cells. Htf is a key regulator of hematopoietic stem cell (HSC) proliferation and has been implicated in the development and treatment of various diseases, including heart failure, cancer, and autoimmune disorders.

Htr3c, also known as Htf-3c, is a specific subunit of the Htf protein that has been shown to have unique functions in HSC proliferation and differentiation. Htr3c has been identified as a potential drug target in the treatment of various diseases, including heart failure, cancer, and autoimmune disorders.

Diseases and Their Impact on Human Health

Heart failure is a condition that affects the heart's ability to pump blood throughout the body. It is a leading cause of morbidity and mortality, and its symptoms can be severe and progressive. Heart failure is often treated with diuretics, beta-blockers, and ACE inhibitors, which can improve cardiac function and reduce symptoms. However, these treatments can have significant side effects, and there is a need for new and more effective therapies.

Cancer is a leading cause of morbidity and mortality, with over 20 million new cases and 5.5 million deaths in the United States alone each year. The development and progression of cancer can be influenced by various factors, including genetic and environmental factors. Treatment options for cancer have advanced significantly in recent years, but there is still a need for new and more effective therapies to improve outcomes.

Autoimmune disorders are a group of chronic conditions that result from an overactive immune system. They can affect various organs and systems in the body and can cause significant discomfort and disability. Treatment options for autoimmune disorders have advanced in recent years, but there is still a need for new and more effective therapies to improve outcomes.

HTR3c as a Drug Target

HTR3c has been shown to have unique functions in HSC proliferation and differentiation. Htr3c has been shown to play a role in the regulation of stem cell proliferation and has been implicated in the development and treatment of various diseases.

One of the most significant functions of Htr3c is its role in the regulation of HSC proliferation. Htr3c has been shown to promote the self-renewal and proliferation of HSCs, which are important for the development and maintenance of various tissues in the body. Htr3c has also been shown to regulate the differentiation of HSCs into functional cells that can replace damaged or dysfunctional tissues.

In addition to its role in HSC proliferation and differentiation, Htr3c has also been shown to play a role in the regulation of immune cells. Htr3c has been shown to regulate the activity of immune cells, including T cells and natural killer cells, which are important for immune surveillance and defense against infection.

Molecular Mechanisms

Htr3c has been shown to have unique functions in HSC proliferation and differentiation by regulating various signaling pathways. Htr3c has been shown to regulate the activation and proliferation of HSCs through the Src/FAK signaling pathway. This pathway is involved in the regulation of cell proliferation, differentiation, and survival, and has been implicated in the development and treatment of various diseases.

Htr3c has also been shown to regulate the differentiation of HSCs into functional cells by suppressing the expression of genes involved in cell adhesion and migration. This regulation of cell behavior is important for the development and maintenance of various tissues in the body, and is a potential target for new therapies.

Preclinical Studies

Preclinical studies have shown that Htr3c can be a valuable drug target for the treatment of various diseases, including heart failure, cancer, and autoimmune disorders. Htr3c has been shown to improve

Protein Name: 5-hydroxytryptamine Receptor 3C

Functions: This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor is a ligand-gated ion channel, which when activated causes fast, depolarizing responses. It is a cation-specific, but otherwise relatively nonselective, ion channel

The "HTR3C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HTR3C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets